Copertina

Network medicine and systems pharmacology approaches to predicting adverse drug effects

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alessio Funari, Giulia Fiscon, Paola Paci
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Network‐based precision medicine and systems pharmacology
di: Arvind K. Pandey, et al.
Pubblicazione: (2025)

Clinical pharmacology in adolescent transgender medicine
di: Lauren R. Cirrincione, et al.
Pubblicazione: (2024)

The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom
di: Simrit Dhillon, et al.
Pubblicazione: (2026)

Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning
di: Sergio Corridore, et al.
Pubblicazione: (2025)

The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions—A backward selection approach
di: Judith Berres, et al.
Pubblicazione: (2026)

Assessment of clinical pharmacology and competence during medicine clerkships
di: Nicole C. Cheung, et al.
Pubblicazione: (2025)

Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin‐3
di: Melissa David, et al.
Pubblicazione: (2025)

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research
di: Titiaan E. Post, et al.
Pubblicazione: (2024)

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024
di: Andreas Papapetropoulos, et al.
Pubblicazione: (2025)

Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa
di: Adrian Steulet, et al.
Pubblicazione: (2024)

Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland
di: Fiona A. Strobel, et al.
Pubblicazione: (2026)

Evaluating a virtual paediatric adverse drug reaction clinic
di: Emily Hauck, et al.
Pubblicazione: (2026)

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding
di: Ida M. Heerfordt, et al.
Pubblicazione: (2025)

Anti‐inflammatory effects of physical stimuli: The central role of networks in shaping the future of pharmacological research
di: Veronica Paparozzi, et al.
Pubblicazione: (2025)

Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events
di: Maeve E. Wickham, et al.
Pubblicazione: (2024)

Economic burden of hospital admissions for adverse drug reactions in France: The IATROSTAT‐ECO study
di: Marie‐Laure Laroche, et al.
Pubblicazione: (2024)

Resolution pharmacology and the treatment of infectious diseases
di: Vivian Vasconcelos Costa, et al.
Pubblicazione: (2024)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
di: Rolien Bosch, et al.
Pubblicazione: (2024)

Bridging the gap between clinical pharmacology and rational drug prescribing 2.0: An up‐date after 30 years
di: Erik M. Donker, et al.
Pubblicazione: (2024)

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
di: Dave Singh, et al.
Pubblicazione: (2026)

Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data
di: Maeve E. Wickham, et al.
Pubblicazione: (2024)

Empowering citizens to spontaneously report suspected adverse drug reaction: Systematic literature review of interventions and their impact
di: Margarida Perdigão, et al.
Pubblicazione: (2026)

A systematic assessment of robustness in CNS safety pharmacology
di: Maria Reiber, et al.
Pubblicazione: (2024)

Natural product pharmacology: the British Journal of Pharmacology perspective
di: Xin Wang, et al.
Pubblicazione: (2024)

Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response
di: Magnus Ingelman‐Sundberg, et al.
Pubblicazione: (2024)

Formative feedback to improve pharmacology learning: Proposed principles and guidelines for effective practice
di: Thomas Anthony Angelo
Pubblicazione: (2026)

An adenosinergic positive feedback loop extends pharmacological cardioprotection duration
di: Gerald Wölkart, et al.
Pubblicazione: (2024)

Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin‐based therapies
di: Ilaria Serra, et al.
Pubblicazione: (2026)

Correction to “Defining and unpacking the core concepts of pharmacology: A global initiative”
Pubblicazione: (2024)

Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39
di: Kira Devantier, et al.
Pubblicazione: (2024)

Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics
di: Bharath Srinivasan
Pubblicazione: (2025)

Updates on Mediterranean diet and health status: active ingredients and pharmacological mechanisms
di: Lukas Schwingshackl, et al.
Pubblicazione: (2026)

Novel approaches for drug development against chronic primary pain: A systematic review
di: Valéria Tékus, et al.
Pubblicazione: (2025)

Clinical pharmacology in space for astronauts and earthlings
di: Jens Jordan, et al.
Pubblicazione: (2025)

Assessment of the molecular mechanisms of drug‐induced hidden cardiotoxicity by a multi‐omics approach: The example of rofecoxib
di: Bennet Y. Weber, et al.
Pubblicazione: (2025)

The TREK‐1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension
di: Réka Csáki, et al.
Pubblicazione: (2024)

Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
di: Tahira Foyzun, et al.
Pubblicazione: (2024)

Evaluating the capability of ChatGPT in predicting drug–drug interactions: Real‐world evidence using hospitalized patient data
di: Ramya Padmavathy Radha Krishnan, et al.
Pubblicazione: (2024)

Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine
di: Xiaomeng Zhang, et al.
Pubblicazione: (2026)

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
di: Louise M. Hesketh, et al.
Pubblicazione: (2026)